A new approach to managing prostate cancer is essential

Identification of patients with Fabry disease using routine pathology results: PATHFINDER (eGFR) study.

International journal of clinical practice·2020

Identification of patients with Pompé disease using routine pathology results: PATHFINDER (creatine kinase) study.

Journal of clinical pathology·2019

An audit of research productivity in clinical biochemistry revisited.

JRSM open·2019

Demand management of weekend haematology and clinical biochemistry requests.

International journal of clinical practice·2018

Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors.

The Journal of reproductive medicine·2010

Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.

Expert review of pharmacoeconomics & outcomes research·2009

Local management of second ipsilateral breast cancer events after primary breast-conserving therapy: an international Delphi consensus.

The Lancet. Oncology·2026

Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.

The Lancet. Oncology·2026

Advancing oncology education in low-income and middle-income African settings: global insights for local action.

The Lancet. Oncology·2026

Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

The Lancet. Oncology·2026

Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

The Lancet. Oncology·2026

Metastatic Urothelial Carcinoma of the Bladder to the Retina: A Clinicopathological Correlation and Review of the Literature.

Retina (Philadelphia, Pa.)·2026

Preoperative Diagnosis of the Bile Duct Traumatic Neuroma by Endoscopic Ultrasound-guided Tissue Acquisition: A Case Report.

DEN open·2026

Severe hypercalcemia in a patient with end-stage liver disease.

JCEM case reports·2026

Endoscopic submucosal dissection for a giant circumferential early rectal cancer with massive schistosoma egg deposition: a case report.

Frontiers in surgery·2026

UNC93B1 drives IL-6/STAT3-dependent tumor-macrophage crosstalk and epithelial-mesenchymal transition in breast cancer.

Frontiers in pharmacology·2026

Early esophageal squamous neoplasia and the microbiome: evidence, mechanisms, and early-detection potential.

Frontiers in microbiology·2026

Related Experiment Videos

A new approach to managing prostate cancer is essential

Related Concept Videos

Identification of patients with Fabry disease using routine pathology results: PATHFINDER (eGFR) study.

Identification of patients with Pompé disease using routine pathology results: PATHFINDER (creatine kinase) study.

An audit of research productivity in clinical biochemistry revisited.

Demand management of weekend haematology and clinical biochemistry requests.

Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors.

Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.

Local management of second ipsilateral breast cancer events after primary breast-conserving therapy: an international Delphi consensus.

Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research.

Advancing oncology education in low-income and middle-income African settings: global insights for local action.

Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

Postmastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year quality-of-life results from a randomised, controlled, phase 3 trial.

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial.

Metastatic Urothelial Carcinoma of the Bladder to the Retina: A Clinicopathological Correlation and Review of the Literature.

Preoperative Diagnosis of the Bile Duct Traumatic Neuroma by Endoscopic Ultrasound-guided Tissue Acquisition: A Case Report.

Severe hypercalcemia in a patient with end-stage liver disease.

Endoscopic submucosal dissection for a giant circumferential early rectal cancer with massive schistosoma egg deposition: a case report.

UNC93B1 drives IL-6/STAT3-dependent tumor-macrophage crosstalk and epithelial-mesenchymal transition in breast cancer.

Early esophageal squamous neoplasia and the microbiome: evidence, mechanisms, and early-detection potential.

Related Experiment Videos

A new approach to managing prostate cancer is essential

Related Concept Videos

Related Articles